IP Hot Shorts June 2021
It has been a constant and collective effort of The IP Press Team to bring to its readers the most recent news in the field […]
patent
IP Hot Shorts May 2021
It has been a constant and collective effort of The IP Press Team to bring to its readers the most recent news in the field […]
Patenting COVID-19 vaccine: Contrary to International obligations?
Introduction The past year has not been easy for most of people across different nations. The novel coronavirus made 2020 difficult and tiring for most […]
PATENT AMENDMENT RULES: A BOON FOR SMALL ENTITIES, START-UPS & EDUCATIONAL INSTITUTIONS
Introduction In the month of October 2020, the Department for the Promotion of Industry and Internal Trade (DPIIT) issued the Patents (Amendment) Rules 2020 (hereinafter […]
India to render IPAB dysfunctional
On 4th April 2021, the Official Gazette has published an ordinance titled Tribunals Reforms (Rationalization and Conditions of Service) Ordinance, 2021(Gazette ID: CG-DL-E-04042021-226364). This Ordinance […]
Report on the Workshop conducted by Adv. Prity Khastgir with The IP Press
Topics: Future of Cross-licensing to Create Patent Pool; The fate of AI-based Innovations; Future perspectives of a career in IPR The Workshop on Future of […]
Nokia V Daimler: Another SEP litigation to discuss!!!
After writing an introductory post on SEP licensing and discussing the steps of SEP licensing negotiation in view of the German case Haier v. Sisvel, […]
Monsanto’s patent took its last breath, undetermined if it was a patent or plant variety
The present blog pertains to the landmark fight over Monsanto’s Bt. Cotton technology. It is not yet finalised whether the subject invention was a patentable […]
Brexit and Unitary patent in the EU: An analysis of what has happened so far.
Failure of the first attempt to establish a unitary patent system Since the conclusion of The European Patent Convention in 1973, there have been several […]
Nothing is new under the moon: second-medical-use and COVID-19 treatment
Under patent law, new uses of known substances can be protected by second medical use patents. It is known that the research in the field […]